Border Patrol: Regulation of Immunity, Inflammation and Tissue Homeostasis at Barrier Surfaces by IL-22

Overview

Journal Nat Immunol

Date 2011 Apr 20

PMID 21502992

Citations 522

Authors

Gregory F Sonnenberg

Lynette A Fouser

David Artis

Affiliations

Soon will be listed here.

Abstract

The maintenance of barrier function at exposed surfaces of the mammalian body is essential for limiting exposure to environmental stimuli, preventing systemic dissemination of commensal and pathogenic microbes and retaining normal homeostasis of the entire body. Indeed, dysregulated barrier function is associated with many infectious and inflammatory diseases, including psoriasis, influenza, inflammatory bowel disease and human immunodeficiency virus, which collectively afflict millions of people worldwide. Studies have shown that interleukin 22 (IL-22) is expressed at barrier surfaces and that its expression is dysregulated in certain human diseases, which suggests a critical role in the maintenance of normal barrier homeostasis. Consistent with that, studies of mouse model systems have identified a critical role for signaling by IL-22 through its receptor (IL-22R) in the promotion of antimicrobial immunity, inflammation and tissue repair at barrier surfaces. In this review we will discuss how the expression of IL-22 and IL-22R is regulated, the functions of the IL-22-IL-22R pathway in regulating immunity, inflammation and tissue homeostasis, and the therapeutic potential of targeting this pathway in human disease.

Citing Articles

Therapeutic Potential of Nutritional Aryl Hydrocarbon Receptor Ligands in Gut-Related Inflammation and Diseases.

Huang F Biomedicines. 2025; 12(12.

PMID: 39767818 PMC: 11673835. DOI: 10.3390/biomedicines12122912.

The role of sodium butyrate in modulating growth, intestinal health, and antimicrobial efficacy in turbot (Scophthalmus maximus L.) fed high soy diets.

Zhang J, Jia C, Dong J, Wu J, Liu M, Zhang H Sci Rep. 2024; 14(1):32033.

PMID: 39739006 PMC: 11685986. DOI: 10.1038/s41598-024-83704-w.

Dissecting Innate and Adaptive Immunity in Inflammatory Bowel Disease: Immune Compartmentalization, Microbiota Crosstalk, and Emerging Therapies.

Yue N, Hu P, Tian C, Kong C, Zhao H, Zhang Y J Inflamm Res. 2024; 17:9987-10014.

PMID: 39634289 PMC: 11615095. DOI: 10.2147/JIR.S492079.

Overview of the development, characterization, and function of human types 1, 2, and 3 innate lymphoid cells.

Bento L, Bacal N, Marti L Einstein (Sao Paulo). 2024; 22:eRW1042.

PMID: 39630753 PMC: 11634355. DOI: 10.31744/einstein_journal/2024RW1042.

Oral exposure to high concentrations of polystyrene microplastics alters the intestinal environment and metabolic outcomes in mice.

Hasegawa Y, Okamura T, Ono Y, Ichikawa T, Saijo Y, Nakanishi N Front Immunol. 2024; 15:1407936.

PMID: 39600697 PMC: 11588728. DOI: 10.3389/fimmu.2024.1407936.

References

Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan A . IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-44. PMC: 2157567. DOI: 10.1172/JCI33194. View

Wolk K, Kunz S, Asadullah K, Sabat R . Cutting edge: immune cells as sources and targets of the IL-10 family members?. J Immunol. 2002; 168(11):5397-402. DOI: 10.4049/jimmunol.168.11.5397. View

Hamada H, Garcia-Hernandez M, Reome J, Misra S, Strutt T, McKinstry K . Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol. 2009; 182(6):3469-81. PMC: 2667713. DOI: 10.4049/jimmunol.0801814. View

Sawa S, Cherrier M, Lochner M, Satoh-Takayama N, Fehling H, Langa F . Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science. 2010; 330(6004):665-9. DOI: 10.1126/science.1194597. View

Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M . Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009; 31(2):321-30. DOI: 10.1016/j.immuni.2009.06.020. View

Ma H, Liang S, Li J, Napierata L, Brown T, Benoit S . IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest. 2008; 118(2):597-607. PMC: 2200300. DOI: 10.1172/JCI33263. View

Hughes T, Becknell B, Freud A, McClory S, Briercheck E, Yu J . Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity. 2010; 32(6):803-14. PMC: 3742307. DOI: 10.1016/j.immuni.2010.06.007. View

Tachiiri A, Imamura R, Wang Y, Fukui M, Umemura M, Suda T . Genomic structure and inducible expression of the IL-22 receptor alpha chain in mice. Genes Immun. 2003; 4(2):153-9. DOI: 10.1038/sj.gene.6363934. View

Zenewicz L, Yancopoulos G, Valenzuela D, Murphy A, Stevens S, Flavell R . Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity. 2008; 29(6):947-57. PMC: 3269819. DOI: 10.1016/j.immuni.2008.11.003. View

10.

Vonarbourg C, Mortha A, Bui V, Hernandez P, Kiss E, Hoyler T . Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity. 2010; 33(5):736-51. PMC: 3042726. DOI: 10.1016/j.immuni.2010.10.017. View

11.

Shen H, Goodall J, Gaston J . Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 2009; 60(6):1647-56. DOI: 10.1002/art.24568. View

12.

Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld J . Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 2009; 60(2):390-5. DOI: 10.1002/art.24220. View

13.

Buonocore S, Ahern P, Uhlig H, Ivanov I, Littman D, Maloy K . Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010; 464(7293):1371-5. PMC: 3796764. DOI: 10.1038/nature08949. View

14.

de Jong A, Pena-Cruz V, Cheng T, Clark R, van Rhijn I, Moody D . CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire. Nat Immunol. 2010; 11(12):1102-9. PMC: 3131223. DOI: 10.1038/ni.1956. View

15.

Zheng Y, Valdez P, Danilenko D, Hu Y, Sa S, Gong Q . Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008; 14(3):282-9. DOI: 10.1038/nm1720. View

16.

Ciric B, El-Behi M, Cabrera R, Zhang G, Rostami A . IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol. 2009; 182(9):5296-305. DOI: 10.4049/jimmunol.0900036. View

17.

Nograles K, Zaba L, Shemer A, Fuentes-Duculan J, Cardinale I, Kikuchi T . IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol. 2009; 123(6):1244-52.e2. PMC: 2874584. DOI: 10.1016/j.jaci.2009.03.041. View

18.

Minegishi Y, Saito M, Tsuchiya S, Tsuge I, Takada H, Hara T . Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007; 448(7157):1058-62. DOI: 10.1038/nature06096. View

19.

Colin E, Asmawidjaja P, van Hamburg J, Mus A, van Driel M, Hazes J . 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 2009; 62(1):132-42. DOI: 10.1002/art.25043. View

20.

Radaeva S, Sun R, Pan H, Hong F, Gao B . Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology. 2004; 39(5):1332-42. DOI: 10.1002/hep.20184. View